[Manipulation of Th17-mediated autoimmunity by targeting nuclear receptors].
Oki
Shinji
S
Department of Immunology, National Institute of Neuroscience, NCNP, Kodaira, Tokyo, Japan.
D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D015551:Autoimmunity / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D006801:Humans; D018836:Inflammation Mediators; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2 / Q000502:physiology; D057093:Orphan Nuclear Receptors / Q000502:physiology*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology* / Q000378:metabolism
D016207:Cytokines; D018836:Inflammation Mediators; C539882:NR4A2 protein, human; D057126:Nuclear Receptor Subfamily 4, Group A, Member 2; D057093:Orphan Nuclear Receptors